EI
BIO icon

EAM Investors’s Bio-Rad Laboratories Class A BIO Stock Holding History

EAM Investors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-9,424
Closed -$2.13M – 294
2017
Q2 		$2.13M Sell
9,424
-5,152
-35% -$1.12M 0.35% 148
2017
Q1 		$2.91M Sell
14,576
-6,532
-31% -$1.26M 0.46% 92
2016
Q4 		$3.85M Buy
21,108
+3,115
+17% +$531K 0.51% 31
2016
Q3 		$2.95M Buy
+17,993
New +$2.73M 0.4% 96
2016
Q1 		– Sell
-24,370
Closed -$3.38M – 297
2015
Q4 		$3.38M Buy
24,370
+5,227
+27% +$725K 0.44% 82
2015
Q3 		$2.57M Sell
19,143
-4,449
-19% -$640K 0.41% 93
2015
Q2 		$3.55M Sell
23,592
-1,867
-7% -$267K 0.42% 81
2015
Q1 		$3.44M Buy
+25,459
New +$3.16M 0.4% 94

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return